BroadOak Capital Partners is a life sciences-focused investment and advisory firm that provides direct growth capital to commercial and growth-stage companies in the life sciences tools, services, diagnostics, and biopharma services sectors. Their strategy involves a flexible investment structure, a long-term horizon, and active partnership, often as the first institutional investor for underserved companies.
67% of their portfolio is in Biotech & Life Sciences. They made 2 investments in the last 12 months.
Portfolio
3
Fund Size
—
Top Stage
Growth
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Codis | Growth | — | Oct 2025 |
 KROMATID | Series C | $8M | Aug 2025 |
 PBS Biotech | Unknown | $22M | Jan 2023 |
Top Co-Investors
Avego Management, LLC1 shared
Last updated: 28 April 2026